Mohammed Al‐Omran - Concepedia

Author

Mohammed Al‐Omran

Also Known As

Al-Omran M., Amjad Al-Quraini, Konrad Salata, M Al-Omran, M. AL‐OMRAN, M. Al-Omran, Manuel Méndez-Bailón, Mohammed A Al-Omran, Mohammed A. Al-Omran, Mohammed Al-Omran

335

Publications

10K

Citations

H-Index

144

Concepts

All Affiliations

University of Toronto St. Michael's Hospital King Saud University University Health Network Institute for Clinical Evaluative Sciences

About

Mohammed Al‐Omran is an author at University of Toronto specializing in medicine, cardiovascular disease, and vascular surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	49	2.4K
2	Engineering	3	3	51
3	Health Sciences	3	3	395
4	Education	1	1	22
5	Natural Sciences	1	1	14

Mohammed Al‐Omran

104

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease Subodh Verma, C. David Mazer, Andrew T. Yan, Circulation	2019	550
Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis Fina Lovren, Yi Pan, Adrian Quan, American Journal of Physiology-Heart and Circulatory Physiology InflammationMolecular PharmacologyHypertensionVascular DiseaseAngiogenesis	2008	303
Adropin Is a Novel Regulator of Endothelial Function Fina Lovren, Yi Pan, Adrian Quan, Circulation	2010	299
Effects of Nitric Oxide on Cell Proliferation Claudio Napoli, Giuseppe Paolisso, Amelia Casamassimi, Journal of the American College of Cardiology InflammationReactive Nitrogen SpecieNitric OxidePhysiologyCell Proliferation	2013	278
MicroRNA-145 Targeted Therapy Reduces Atherosclerosis Fina Lovren, Yi Pan, Adrian Quan, Circulation	2012	275
Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages Fina Lovren, Yi Pan, Adrian Quan, American Journal of Physiology-Heart and Circulatory Physiology	2010	217
Epidemiologic features of acute appendicitis in Ontario, Canada. Mohammed Al‐Omran, Muhammad Mamdani, Robin S. McLeod PubMed	2003	199
BRCA1 is an essential regulator of heart function and survival following myocardial infarction Praphulla Chandra Shukla, Krishna K. Singh, Adrian Quan, Nature Communications	2011	147
Rosiglitazone Facilitates Angiogenic Progenitor Cell Differentiation Toward Endothelial Lineage Chao‐Hung Wang, Nadia Ciliberti, Shuhong Li, Circulation	2004	144
The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension Biswajit Chowdhury, Albert Z. Luu, Vincent Z. Luu, Biochemical and Biophysical Research Communications HypertensionPulmonary Arterial HypertensionCardiovascular DiseaseExperimental Pulmonary HypertensionPharmacology	2020	136

Page 1